ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Rockwell Automation (Kalypso) Recognized as a Representative Vendor in 2024 Gartner® Market Guide for Life Science Regulatory Information Management Solutions

Kalypso, a Rockwell Automation (NYSE: ROK) business, today announced its inclusion as a Representative Vendor in the 2024 Gartner® Market Guide for Life Science Regulatory Information Management (RIM) Solutions. Kalypso was recognized for its Digital Regulatory Information Management solution tailored for the medical device industry.

Gartner notes that “Regulatory information management vendors continue to innovate and consolidate solutions into integrated platforms for greater optimization and automation.” The report further highlights that Life science CIOs want to reduce the complexity of their regulatory IT systems and accompanying traditional business processes to speed regulatory submissions and lower costs.

Kalypso’s RIM solution is designed to help life sciences companies bring compliant products to global markets faster, while meeting country-specific regulatory requirements. The platform enables organizations to manage and track product registrations, improve submission accuracy, manage global UDI data, and support efficient product distribution—all within a unified, integrated system.

“We believe our recognition in Gartner’s Market Guide validates our commitment to delivering a cost-effective, scalable accelerator for RIM system implementation,” said Rod Walters, Lead Principal, Life Sciences at Kalypso. “Our solution consolidates compliance and quality data from across the enterprise into a single source of truth, enabling faster, more accurate regulatory submissions and global market access.”

As life sciences companies face increasing pressure to scale internationally, the need for a globally unified approach to product registration, submission, and market tracking has never been more critical. ‘’Vendors that focus on end-to-end regulatory information management (RIM) address these challenges by reducing unnecessary preproduction work, quality checks and complex system integrations via middleware solutions.’’

“Non-compliance is not an option—it’s costly, damaging to brand reputation, and potentially harmful to patients,” Walters added.

For more information about Kalypso’s Digital RIM solutions, visit www.kalypso.com.

(1) Gartner, Inc. "Market Guide for Life Science Regulatory Information Management Solutions" by Jeff Smith, September 2, 2024

Gartner Disclaimer

GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and is used herein with permission. All rights reserved.

Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

About Rockwell Automation

Rockwell Automation, Inc. (NYSE: ROK) is a global leader in industrial automation and digital transformation. We connect the imaginations of people with the potential of technology to expand what is humanly possible, making the world more productive and more sustainable. Headquartered in Milwaukee, Wisconsin, Rockwell Automation employs approximately 27,000 problem solvers dedicated to our customers in more than 100 countries as of fiscal year end 2024. To learn more about how we are bringing the Connected Enterprise® to life across industrial enterprises, visit www.rockwellautomation.com.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.